{"id":"https://openalex.org/W4408502000","doi":"https://doi.org/10.1038/s41564-025-01955-3","title":"Drug\u2013Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice","display_name":"Drug\u2013Fc conjugate CD388 targets influenza virus neuraminidase and is broadly protective in mice","publication_year":2025,"publication_date":"2025-03-17","ids":{"openalex":"https://openalex.org/W4408502000","doi":"https://doi.org/10.1038/s41564-025-01955-3","pmid":"https://pubmed.ncbi.nlm.nih.gov/40097766","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11964917"},"language":"en","primary_location":{"id":"doi:10.1038/s41564-025-01955-3","doi":"https://doi.org/10.1038/s41564-025-01955-3","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41564-025-01955-3","pdf_url":null,"source":{"id":"https://openalex.org/S2764926557","display_name":"Nature Microbiology","issn_l":"2058-5276","issn":["2058-5276"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Microbiology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1038/s41564-025-01955-3","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023107683","display_name":"Simon D\u00f6hrmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Simon D\u00f6hrmann","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112599402","display_name":"James M Levin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Levin","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064006920","display_name":"Jason N. Cole","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason N. Cole","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033169749","display_name":"Allen Borchardt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Allen Borchardt","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076930062","display_name":"Karin Amundson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karin Amundson","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077244168","display_name":"Amanda L. Almaguer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Almaguer","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041658712","display_name":"Elizabeth Abelovski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth Abelovski","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104320373","display_name":"Rajvir Grewal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajvir Grewal","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043986373","display_name":"Douglas E. Zuill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas Zuill","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034341152","display_name":"Nicholas Dedeic","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Dedeic","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049077059","display_name":"Grayson Hough","orcid":"https://orcid.org/0009-0003-4960-2811","observed_orcids":["https://orcid.org/0009-0003-4960-2811"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Grayson Hough","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090771280","display_name":"Joanne Fortier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanne Fortier","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014735120","display_name":"Joanna L. Donatelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joanna Donatelli","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039881624","display_name":"Thanh Lam","orcid":"https://orcid.org/0000-0002-4749-6096","observed_orcids":["https://orcid.org/0000-0002-4749-6096"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thanh Lam","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101544000","display_name":"Zhiyong Chen","orcid":"https://orcid.org/0000-0001-5032-8280","observed_orcids":["https://orcid.org/0000-0001-5032-8280"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhi-Yong Chen","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011116864","display_name":"Wanlong Jiang","orcid":"https://orcid.org/0009-0009-7835-665X","observed_orcids":["https://orcid.org/0009-0009-7835-665X"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wanlong Jiang","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055936811","display_name":"Travis J. Haussener","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Travis Haussener","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084759486","display_name":"Alain Noncovich","orcid":"https://orcid.org/0009-0003-9088-0434","observed_orcids":["https://orcid.org/0009-0003-9088-0434"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alain Noncovich","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010189871","display_name":"James M. Balkovec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James M. Balkovec","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078707644","display_name":"Daniel C. Bensen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel C. Bensen","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090249918","display_name":"Voon S. Ong","orcid":"https://orcid.org/0000-0001-8676-6717","observed_orcids":["https://orcid.org/0000-0001-8676-6717"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Voon Ong","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111912606","display_name":"Thomas P. Brady","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas P. Brady","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010350552","display_name":"Jeffrey B. Locke","orcid":"https://orcid.org/0000-0001-8145-0828","observed_orcids":["https://orcid.org/0000-0001-8145-0828"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey B. Locke","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":"https://orcid.org/0000-0001-8145-0828","affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017328552","display_name":"Shawn D. Flanagan","orcid":"https://orcid.org/0000-0003-0464-9301","observed_orcids":["https://orcid.org/0000-0003-0464-9301"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shawn Flanagan","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":"https://orcid.org/0000-0003-0464-9301","affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015871731","display_name":"Robert M. Hughes","orcid":"https://orcid.org/0000-0002-4465-4212","observed_orcids":["https://orcid.org/0000-0002-4465-4212"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Hughes","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jeffrey L. Stein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey L. Stein","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111080803","display_name":"Leslie W. Tari","orcid":"https://orcid.org/0009-0008-8621-3299","observed_orcids":["https://orcid.org/0009-0008-8621-3299"]},"institutions":[{"id":"https://openalex.org/I4210140218","display_name":"Cidara Therapeutics (United States)","ror":"https://ror.org/044pnsw08","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140218"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Leslie W. Tari","raw_affiliation_strings":["Cidara Therapeutics, San Diego, CA, USA. ltari@cidara.com","Cidara Therapeutics, San Diego, CA, USA"],"raw_orcid":"https://orcid.org/0009-0008-8621-3299","affiliations":[{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA. ltari@cidara.com","institution_ids":["https://openalex.org/I4210140218"]},{"raw_affiliation_string":"Cidara Therapeutics, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210140218"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111080803"],"corresponding_institution_ids":["https://openalex.org/I4210140218"],"apc_list":{"value":12690,"currency":"USD","value_usd":12690},"apc_paid":{"value":12690,"currency":"USD","value_usd":12690},"fwci":13.1161,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.99319545,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"10","issue":"4","first_page":"912","last_page":"926"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10167","display_name":"Influenza Virus Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/influenza-neuraminidase","display_name":"influenza neuraminidase","score":0.800000011920929},{"id":"https://openalex.org/keywords/zanamivir","display_name":"zanamivir","score":0.996999979019165},{"id":"https://openalex.org/keywords/neuraminidase-inhibitor-resistance","display_name":"neuraminidase inhibitor resistance","score":0.800000011920929},{"id":"https://openalex.org/keywords/influenza-a-virus","display_name":"influenza A virus","score":0.6859999895095825},{"id":"https://openalex.org/keywords/influenza-b","display_name":"influenza B","score":1.0},{"id":"https://openalex.org/keywords/extended-half-life","display_name":"extended half-life","score":0.746999979019165},{"id":"https://openalex.org/keywords/antiviral-resistance","display_name":"antiviral resistance","score":0.5770000219345093},{"id":"https://openalex.org/keywords/prophylaxis","display_name":"prophylaxis","score":0.8059999942779541},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.8230000138282776},{"id":"https://openalex.org/keywords/mouse-model-of-infection","display_name":"mouse infection model","score":0.460999995470047},{"id":"https://openalex.org/keywords/cynomolgus-macaques","display_name":"cynomolgus macaques","score":0.9610000252723694}],"concepts":[{"id":"https://openalex.org/C134164806","wikidata":"https://www.wikidata.org/wiki/Q409485","display_name":"Neuraminidase","level":3,"score":0.8059518337249756},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.7293592095375061},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.6767081618309021},{"id":"https://openalex.org/C2777538117","wikidata":"https://www.wikidata.org/wiki/Q425196","display_name":"Neuraminidase inhibitor","level":5,"score":0.6662207245826721},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6030651330947876},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5324937701225281},{"id":"https://openalex.org/C2777546802","wikidata":"https://www.wikidata.org/wiki/Q834390","display_name":"Influenza A virus","level":3,"score":0.44170430302619934},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3756718039512634},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.36969655752182007},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2835080027580261},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.27519500255584717},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.10005801916122437},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007141","descriptor_name":"Immunoglobulin Fc Fragments","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D007251","descriptor_name":"Influenza, Human","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009439","descriptor_name":"Neuraminidase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D009976","descriptor_name":"Orthomyxoviridae Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009976","descriptor_name":"Orthomyxoviridae Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D009976","descriptor_name":"Orthomyxoviridae Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D009980","descriptor_name":"Influenza A virus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009980","descriptor_name":"Influenza A virus","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D009981","descriptor_name":"Influenza B virus","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009981","descriptor_name":"Influenza B virus","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D014764","descriptor_name":"Viral Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053243","descriptor_name":"Zanamivir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D053243","descriptor_name":"Zanamivir","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D053243","descriptor_name":"Zanamivir","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1038/s41564-025-01955-3","doi":"https://doi.org/10.1038/s41564-025-01955-3","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41564-025-01955-3","pdf_url":null,"source":{"id":"https://openalex.org/S2764926557","display_name":"Nature Microbiology","issn_l":"2058-5276","issn":["2058-5276"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Microbiology","raw_type":"journal-article"},{"id":"doi:10.1101/2024.06.04.597465","doi":"https://doi.org/10.1101/2024.06.04.597465","is_oa":true,"landing_page_url":"https://doi.org/10.1101/2024.06.04.597465","pdf_url":null,"source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nd","license_id":"https://openalex.org/licenses/cc-by-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},{"id":"pmh:oai:pubmedcentral.nih.gov:11964917","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11964917/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11964917/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nat Microbiol","raw_type":"Text"},{"id":"pmid:40097766","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40097766","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature microbiology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/s41564-025-01955-3","doi":"https://doi.org/10.1038/s41564-025-01955-3","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41564-025-01955-3","pdf_url":null,"source":{"id":"https://openalex.org/S2764926557","display_name":"Nature Microbiology","issn_l":"2058-5276","issn":["2058-5276"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Microbiology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320312222","display_name":"Cidara Therapeutics","ror":"https://ror.org/044pnsw08"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4408502000.pdf","grobid_xml":"https://content.openalex.org/works/W4408502000.grobid-xml"},"referenced_works_count":59,"referenced_works":["https://openalex.org/W1483512866","https://openalex.org/W1784292360","https://openalex.org/W1968256827","https://openalex.org/W1969846931","https://openalex.org/W1982413916","https://openalex.org/W1989368177","https://openalex.org/W1996045402","https://openalex.org/W2002406378","https://openalex.org/W2003926950","https://openalex.org/W2013876235","https://openalex.org/W2014018866","https://openalex.org/W2019896390","https://openalex.org/W2020585508","https://openalex.org/W2022396428","https://openalex.org/W2040883346","https://openalex.org/W2046182783","https://openalex.org/W2046745698","https://openalex.org/W2046926288","https://openalex.org/W2047400336","https://openalex.org/W2051272737","https://openalex.org/W2086358466","https://openalex.org/W2096387523","https://openalex.org/W2105842989","https://openalex.org/W2136713302","https://openalex.org/W2146498185","https://openalex.org/W2152581975","https://openalex.org/W2153254433","https://openalex.org/W2158073495","https://openalex.org/W2161100389","https://openalex.org/W2163135112","https://openalex.org/W2164759517","https://openalex.org/W2338736253","https://openalex.org/W2472358435","https://openalex.org/W2491163602","https://openalex.org/W2555334376","https://openalex.org/W2575638356","https://openalex.org/W2593080252","https://openalex.org/W2727086257","https://openalex.org/W2795794761","https://openalex.org/W2795900571","https://openalex.org/W2801746406","https://openalex.org/W2890167384","https://openalex.org/W2892275685","https://openalex.org/W2912259525","https://openalex.org/W2919790473","https://openalex.org/W2946337557","https://openalex.org/W2975746568","https://openalex.org/W2981536928","https://openalex.org/W3012130088","https://openalex.org/W3013585362","https://openalex.org/W3125227243","https://openalex.org/W4210997720","https://openalex.org/W4244378661","https://openalex.org/W4308496866","https://openalex.org/W4313593131","https://openalex.org/W4378800594","https://openalex.org/W4381469819","https://openalex.org/W4400876000","https://openalex.org/W6808746003"],"related_works":["https://openalex.org/W4399355952","https://openalex.org/W7122385737","https://openalex.org/W4414964693","https://openalex.org/W4389031889","https://openalex.org/W4406950372","https://openalex.org/W4389029178","https://openalex.org/W4389031045","https://openalex.org/W7218593335","https://openalex.org/W4406923547","https://openalex.org/W4409219832"],"abstract_inverted_index":{"The":[0],"ability":[1],"of":[2,50,68,81,93,138],"influenza":[3,20,32,70,100,139,168],"virus":[4,71],"to":[5,10,76],"undergo":[6],"rapid":[7],"antigenic":[8],"shift":[9],"elude":[11],"humoral":[12],"immunity":[13],"highlights":[14],"the":[15,45,69,90,133],"need":[16],"for":[17,22,85,116,135,156],"effective":[18],"broad-spectrum":[19],"antivirals":[21],"treatment,":[23],"prophylaxis":[24],"and":[25,36,47,60,102,108,119,141,145,163,170],"pandemic":[26],"preparedness.":[27],"Strategies":[28],"providing":[29],"durable,":[30],"universal":[31,97,136],"protection":[33],"in":[34,58,122,143,173],"healthy":[35,144],"high-risk":[37,146],"populations":[38],"are":[39],"urgently":[40],"needed.":[41],"Here":[42],"we":[43],"describe":[44],"design":[46],"preclinical":[48],"characterization":[49],"CD388,":[51],"a":[52,65,77,113,150],"first-in-class":[53,151],"antiviral":[54,91,152],"drug\u2013Fc":[55,153],"conjugate":[56,67,154],"(DFC),":[57],"mice":[59],"cynomolgus":[61],"macaques.":[62],"CD388":[63,88,131,148],"comprises":[64],"multivalent":[66],"neuraminidase":[72,109],"inhibitor":[73,110],"zanamivir,":[74,94],"linked":[75],"CH1\u2013Fc":[78],"hybrid":[79],"domain":[80],"human":[82],"IgG1":[83],"engineered":[84,155],"extended":[86,157],"half-life.":[87],"improves":[89],"activity":[92,98],"demonstrating":[95],"potent,":[96],"across":[99],"A":[101,140,169],"B":[103,142,171],"viruses,":[104],"including":[105],"high":[106],"pathogenicity":[107],"resistant":[111],"strains,":[112],"low":[114],"potential":[115,134],"resistance":[117],"development":[118],"potent":[120,161],"efficacy":[121,165],"lethal":[123,167],"mouse":[124],"infection":[125],"models.":[126],"These":[127],"results":[128],"suggest":[129],"that":[130,159],"has":[132],"prevention":[137],"populations.":[147],"is":[149],"half-life":[158],"demonstrates":[160],"prophylactic":[162],"therapeutic":[164],"against":[166],"challenge":[172],"mice.":[174]},"counts_by_year":[{"year":2026,"cited_by_count":16},{"year":2025,"cited_by_count":8}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-03-17T00:00:00"}